Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease

J Gastrointestin Liver Dis. 2020 Dec 12;29(4):487-489. doi: 10.15403/jgld-3234.

Authors

Susumu Ohya¹, Miki Matsui², Junko Kajikuri³

Affiliations

¹ Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan. sohya@med.nagoya-cu.ac.jp.
² Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan. miki.matsui.4238@gmail.com.
³ Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan. kajikuri@med.nagoya-cu.ac.jp.

PMID: 33331332
DOI: 10.15403/jgld-3234

No abstract available

Publication types

Editorial
Comment

MeSH terms

Colitis*
Humans
Inflammatory Bowel Diseases* / drug therapy
Intermediate-Conductance Calcium-Activated Potassium Channels
Potassium Channels

Substances

Intermediate-Conductance Calcium-Activated Potassium Channels
KCNN4 protein, human
Potassium Channels